You have 9 free searches left this month | for more free features.

Condition

Diffuse Large B-cell Lymphoma (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

Hoffmann-La Roche (1)

Collaborator

Intervention

gemcitabine (1)

glofitamab (1)

obinutuzumab (1)

oxaliplatin (1)

rituxumab (1)

tocilizumab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

rituxumab

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Diffuse Large B-cell Lymphoma Trial in Worldwide (Obinutuzumab, Glofitamab, Rituxumab)

Recruiting

Diffuse Large B-cell Lymphoma

Obinutuzumab
+5 more

Birmingham, Alabama
+77 more

Jul 25, 2022